Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1
摘要:
Influenza is a continuing world-wide public health problem that causes significant morbidity and mortality during seasonal epidemics and sporadic pandemics. The existing vaccination program is variably effective from year to year, and drug resistance to available antivirals is a growing problem, making the development of additional antivirals an important challenge. Influenza virus non-structural protein 1 (NS1) is the centerpiece of the viral response to the host interferon (IFN) system. NS1 was demonstrated previously to be a potential therapeutic target for antiviral therapy by the identification of specific small-molecule inhibitors. One inhibitory compound, NSC125044, was subjected to chemical evaluation. Initial synthetic work comprised simplifying the core structure by removing unwanted functionality and determination of key features important for activity. Several subclasses of molecules were designed and synthesized to further probe activity and develop the basis for a structure-activity relationship. Apparent potency, as judged by activity in virus replication assays, increased dramatically for some analogs, without cytotoxicity. Results suggest that the target binding site tolerates hydrophobic bulk as well as having a preference for weakly basic substituents. (C) 2011 Elsevier Ltd. All rights reserved.
Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1
作者:Joseph J. Jablonski、Dipwanita Basu、Daniel A. Engel、H. Mario Geysen
DOI:10.1016/j.bmc.2011.10.026
日期:2012.1
Influenza is a continuing world-wide public health problem that causes significant morbidity and mortality during seasonal epidemics and sporadic pandemics. The existing vaccination program is variably effective from year to year, and drug resistance to available antivirals is a growing problem, making the development of additional antivirals an important challenge. Influenza virus non-structural protein 1 (NS1) is the centerpiece of the viral response to the host interferon (IFN) system. NS1 was demonstrated previously to be a potential therapeutic target for antiviral therapy by the identification of specific small-molecule inhibitors. One inhibitory compound, NSC125044, was subjected to chemical evaluation. Initial synthetic work comprised simplifying the core structure by removing unwanted functionality and determination of key features important for activity. Several subclasses of molecules were designed and synthesized to further probe activity and develop the basis for a structure-activity relationship. Apparent potency, as judged by activity in virus replication assays, increased dramatically for some analogs, without cytotoxicity. Results suggest that the target binding site tolerates hydrophobic bulk as well as having a preference for weakly basic substituents. (C) 2011 Elsevier Ltd. All rights reserved.
Visible light bromide catalysis for oxazoline, pyrrolidine, and dihydrooxazine syntheses <i>via</i> C<sub>sp<sup>3</sup></sub>–H functionalizations
作者:Navdeep Kaur、Elizabeth C. Ziegelmeyer、Olutayo N. Farinde、Jonathon T. Truong、Michelle M. Huynh、Wei Li
DOI:10.1039/d1cc04588a
日期:——
(N)-centered radical for a site-selective hydrogenatomtransfer (HAT) process. This strategy enabled the unconventional syntheses of a number of N-heterocycles dependent on the amide identity. We also discovered a nucleophilicity-dependent kinetic resolution for stereochemical differentiation of Csp3–H bonds that enabled the stereoselective synthesis of cis- and trans-oxazolines.
此处描述了催化苄基 C sp 3 –H 功能化协议。这种可见光介导的过程集中在利用溴化物催化剂和氧化剂来生成以氮 (N) 为中心的自由基,用于位点选择性氢原子转移 (HAT) 过程。这种策略使依赖酰胺身份的许多 N-杂环的非常规合成成为可能。我们还发现了 C sp 3 -H 键立体化学分化的亲核依赖性动力学分辨率,这使得顺式和反式恶唑啉的立体选择性合成成为可能。